Bordetella pertussis infection in household contacts of cases of pertussis in the southeast zone of the city of Cali, Colombia, 2006-2007
Article Sidebar
Main Article Content
Objective: to learn of the proportion of infection by B. pertussis among suspected cases of whooping cough and their household contacts among children from the southeast zone of Cali, a geographic area with great consultation demand due to this infection.
Methodology: This is a cross-sectional descriptive study. Epidemiological data and nasopharyngeal samples were taken from 24 suspected cases and from their 109 household contacts. The samples were analyzed via real-time polymerase chain reaction (Q-PCR) and through culture.
Results: The proportion of positivity among the cases via the Q-PCR technique was at 50% (12/24) and at 40% via the culture technique (8/20), with good agreement between both techniques (Kappa 0.61). Regarding the household contacts, 30.3% (33/109) (CI 95%: 21.8%-39.8%) tested positive. The sibling contacts (7/15) and the mothers (7/22) presented the greatest proportion of positivity. Regarding age, 60% were 4 years of age (3/5) and 50% were in the group comprised of individuals 45 to 64 years of age. No significant differences were found among the presence or absence of symptoms and the presence of B. pertussis infection, except for the presence of nasal secretions (runny nose) (27%) and coughing (36%) during the last month.
Conclusions: The study confirms the high prevalence of asymptomatic infection by B. pertussis among household contacts of children with whooping cough symptomatology and its household transmission. In Cali, health authorities need to review the effectiveness of implemented control strategies and the use of a vaccination scheme that does not cover adolescent and adult populations as a focus of infection control.
- Bordetella pertussis
- Whooping cough cases and household contacts
World Health Organization. Recommended standards forsurveillance of selected vaccine-preventable diseases. WHO/V7B/03.01. Geneva: WHO; 2003. p. 28-30.2.Aguas R, Goncalves G, Gomes MG. Pertussis: increasingdisease as a consecuence of reducing transmission. LancetInfect Dis. 2006; 6: 112-17.3.Ministerio de la Protección Social, Instituto Nacional deSalud, Colombia. Sistema de Vigilancia en Salud Pública(SIVIGILA). Bogotá: Ministerio de la Protección Social, Ins-tituto Nacional de Salud; 2009.4.Dragsted DM, Dohn B, Madsen J, Jensen JS. Comparison ofculture and PCR for detection of Bordetella pertussis andBordetella parapertussis under routine laboratory conditions.J Med Microbiol. 2004; 53: 749-54.5.García-Martínez J, Cháves F, Salto E, Otero JR. PCR entiempo real, inmunofluorescencia y cultivo para la deteccionde Bordetella pertussis: evaluación prospectiva y epidemio-logía molecular. Enf Infec Microbiol Clin. 2006; 24: 500-4.6.Heininger U, Schmidt-Schlapfer G, Cherry JD, Stehr K.Clinical validation of a polymerase chain reaction assay for thediagnosis of pertussis by comparison with serology, culture,and symptoms during a large pertussis vaccine efficacy trial.Pediatrics. 2000; 105: 31-6.7.Miller SA, Dykes DD, Polesky HF. A simple salting outprocedure for extracting DNA from human nucleated cells.Nucleic Acids Res. 1988; 16: 1215.8.Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, MorrisA, Smith B. Sentinel Health Unit Surveillance System PertussisWorking Group. Pertussis is a frequent cause of prolongedcough illness in adults and adolescents. Clin Infect Dis. 2001;32: 1691-7.9.Cromer BA, Goydos J, Hackell J, Mezzatesta J, Dekker C,Mortimer EA. Unrecognized pertussis infection in adolescents.Am J Dis Child. 1993; 147: 575-7.10. Cruz LF, Girón LN, Velásquez R, García LN, Alzate A.Coberturas de vacunación en el Valle del Cauca 2002. ColombMed. 2003; 34: 17-24.11. Muñoz, FM. Pertussis in infant, children and adolescents:Diagnosis, treatment and prevention. Sem Pediatr Infect Dis.2006; 17: 14-9.12. Sintchenko VN. The emergence of pertussis implications fordiagnosis and surveillance. Public Health Bull. 2008; 19:143-5.13. Tilley G, Kanchana MV, Knigth I, Blondeau J, Antonishyn N,Deneer H. Detection of Bordetella pertussis in a clinicallaboratory by culture, polymerase chain reaction, and directfluorescent antibody staining; accuracy, and cost. DiagnMicrobiol Infect Dis. 2000; 37: 17-3.14. Versteegh F, Mooi-Kokenberg E, Schellekens J, Roord J.Bordetella pertussis and mixed infections. Minerva Pediatr.2006; 58: 131-7.15. Viljanen VK, Ruuskanen O, Granberg C, Salmi TT. Serologicaldiagnosis of pertussis: IgM, IgA, and IgG antibodies againstBordetella pertussis measured by enzyme linked immuno-sorbent assay (ELISA) Scand J Infect Dis. 1982; 14: 117-2.16. Francis M, Borque AC, Del Castillo M, Diez, S García J. Tosferina: Estudio retrospectivo de casos diagnosticados en unperiodo de 15 años. Ann Esp Pediatr. 1998; 49: 280-3.17. Lind-Brandberg L, Welinder-Olsson C, Laggegard T, TarangerJ, Trolifros B, Zackricsson G. Evaluation of PCR for diagnosisof Bordetella pertussis a n d Bordetella parapertussis infections.J Clin Microbiol. 1998; 36: 679-3.18. Silberg S, Njamkepo E, Parent du Chatelet I, Partouche H,Gueirard P, Ghasarissian Schlumberger M, et al. Evidence ofBordetella pertussis infection in adults presenting withpersistent cough in a French area with very high whole -cellvaccine coverage. J Infec Dis. 2002; 186: 415-8.19. Cherry JD. Pertussis in the preantibiotic and prevaccine era,with emphasis on adults pertussis. Clin Infect Dis. 1999; 28(Suppl 2): 107-11.20. Birkebaek NH, Kristiansen M, Seefeldt T, Degn J, Moller A,Heron I, et al.Bordetella pertussis and chronic cough inadults. Clin Infect Dis. 1999; 29: 1239-42.
Downloads
- Miryam Astudillo, Graciela Barona Tovar, Fabio Carmona V., Isolation and identification of coagulase-negative staphylococci from clinical specimens , Colombia Medica: Vol. 24 No. 3 (1993)
- Fabio Carmona, Graciela Barona, Eunice de Alvarez, Miryam Astudillo, Bacteriological studies in the diphtheria epidemic in Buenaventura, Valle, Colombia in 1992 , Colombia Medica: Vol. 24 No. 4 (1993)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use